BioSpace News Archive

Business

Philips shareholders approve all proposals at the AGM 2024

Royal Philips, announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders 2024, including:

May 7, 2024
·
4 min read
BioMidwest

Enable Injections Expands Strategic Partnership with Roche

Enable Injections, Inc. announced the Company has expanded its partnership with Roche through a collaboration, allowing Roche to develop and apply Enable’s expertise and enFuse delivery technology to specific Roche development programs.

May 7, 2024
·
2 min read
Business

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Reneo Pharmaceuticals, Inc., a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, reported financial results for the first quarter ended March 31, 2024.

May 7, 2024
·
5 min read
Policy

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

Invivyd, Inc. announced its intention to submit an emergency use authorization application to the U.S. Food and Drug Administration for pemivibart for the treatment of mild to moderate symptomatic COVID-19 in certain immunocompromised people utilizing a rapid immunobridging pathway.

May 7, 2024
·
14 min read
BioMidwest

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 07, 2024

Abeona Therapeutics Inc. announced it has granted equity awards to new non-executive employees who joined the Company.

May 7, 2024
·
3 min read
Business

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced its financial results for the first quarter ended March 31, 2024 and provided a corporate update.

May 7, 2024
·
17 min read
Genetown

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference 2024

Elevation Oncology, Inc. announced that Joseph J. Ferra, Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 11:30 am ET.

May 7, 2024
·
1 min read
Drug Development

ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event

ASLAN Pharmaceuticals will host a virtual KOL event, during which Company management will present new data from the interim analysis of the Phase 2 TREK-DX study of eblasakimab in dupilumab-experienced atopic dermatitis patients.

May 7, 2024
·
9 min read
Business

Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report

Catheter Precision, Inc. a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ and LockeT product, releases Q1 Financials, Operational Report for the quarter ending March 31, 2024.

May 7, 2024
·
7 min read
Business

Agenus Reports First Quarter 2024 Results

Agenus Inc., a leader in discovering and developing novel immunological agents to treat various cancers, announced results for the first quarter 2024.

May 7, 2024
·
9 min read